Elexacaftor/ivacaftor/tezacaftor
- Generic Name
- Elexacaftor/ivacaftor/tezacaftor
Trikafta for Patients With Non-cystic Fibrosis Bronchiectasis
- First Posted Date
- 2023-02-24
- Last Posted Date
- 2024-07-09
- Lead Sponsor
- Emory University
- Target Recruit Count
- 30
- Registration Number
- NCT05743946
- Locations
- 🇺🇸
The Emory Clinic, Atlanta, Georgia, United States
Trikafta Exercise Study in Cystic Fibrosis
- First Posted Date
- 2022-03-15
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- University of British Columbia
- Target Recruit Count
- 20
- Registration Number
- NCT05279040
- Locations
- 🇨🇦
UBC Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada
Canadian Observational Study Evaluating the Long-term IMPACT of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators on People With CF
- First Posted Date
- 2022-01-20
- Last Posted Date
- 2022-01-20
- Lead Sponsor
- University of British Columbia
- Target Recruit Count
- 500
- Registration Number
- NCT05200429
- Locations
- 🇨🇦
British Columbia Children's Hospital, Vancouver, British Columbia, Canada
🇨🇦St Paul's Hospital, Vancouver, British Columbia, Canada
Trikafta in Cystic Fibrosis Patients
- First Posted Date
- 2018-04-23
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Emory University
- Target Recruit Count
- 42
- Registration Number
- NCT03506061
- Locations
- 🇺🇸
University of Alabama Cystic Fibrosis Research Center, Birmingham, Alabama, United States
🇺🇸Emory Children's Center, Atlanta, Georgia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath